Allied Market Research
Loading...
0
New
New
2021
Medical Cannabis Market

Medical Cannabis Market by Product Type (Buds/Marijuana Flower and Cannabis Extracts), Application (Chronic Pain, Mental Disorders, Cancer, and Others), and End User (Pharmaceutical and Research & Development Centers): Global Opportunity Analysis and Industry Forecast, 2021–2030

A14250
Pages: 229
Oct 2021 | 339 Views
   
Author(s) : Smita Nerkar , Onkar Sumant
Tables: 115
Charts: 41
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Medical Cannabis Market

Request Now !

Medical Cannabis Market Insight - 2030

The global medical cannabis market size was valued at $6,822.21 Million in 2020 and is projected to reach $53,883.46 Million by 2030 registering a CAGR of 23.6% from 2021 to 2030.Medical cannabis, also called medical marijuana, is a herbal drug derived from plants of the genus Cannabis that is used as part of the treatment for a specific symptom or disease such as cancer, chronic pain, and mental disorders. The two major cannabinoids extracted from this plant providing medical benefits include tetrahydrocannabinol (THC) and cannabidiol (CBD).

The medical cannabis market is also facing a period of short-term negative growth, which can be attributed to factors such as a decline in the product demand from major end-users, limited operations in most of the industries, inadequate funding to research and academic institutes, and disrupted supply chain and challenges in terms of providing essential/post-sales services.

Legalization of cannabis across various regions and rise in awareness among consumers regarding health benefits of cannabis and its growing medical application such as treatment of wide range of diseases and symptoms, including cancer, chronic pain, depression, arthritis, diabetes, glaucoma, migraines, epilepsy, multiple sclerosis, acquired immunodeficiency syndrome (AIDS), amyotrophic lateral sclerosis (ALS), Alzheimer’s, post-traumatic stress disorder (PTSD), Parkinson’s, and Tourette’s drive the growth of the medical cannabis market. In addition, novel product development with increased R&D activities fuels growth of the market.

Medical-Cannabis-Market--2021-2030

Get more information on this report : Request Sample Pages

Complex regulatory structure for the usage of cannabis and social stigma related to cannabis are expected to hinder growth of the market during the forecast period. In addition, lack of skilled workforce hampers growth of the market. On the contrary, cannabis legalization in Asia-Pacific is expected to offer profitable opportunities for growth of the medical cannabis market during the forecast period.

Impact of COVID-19 Pandemic on the Medical Cannabis Market  

The outbreak of COVID-19 has disrupted the workflow in the healthcare sector around the world. The disease has forced a number of industries to halt their activities temporarily, including several subdomains of healthcare. The medical cannabis market is further facing a period of short-term negative growth, which can be attributed to factors such as a decline in the product demand from major end-users, limited operations in most of the industries, inadequate funding to research and academic institutes, disrupted supply chain, and challenges in terms of providing essential/post-sales services. For instance, the Netherlands' coffeeshops were initially closed, but later deemed essential businesses. 

In North Macedonia, construction of Pharmacon's 178,000-square-foot cannabis grow house slowed due to of social distancing requirements. Moreover, in Barcelona, Cannabis Social Clubs—private, non-profit organizations, in which cannabis is collectively grown and distributed to registered members, shut their doors following the government's declaration of a state of alarm across the country. 

However, cannabis businesses that offer an e-commerce platform are seeing a surge in business. For instance, cannabis retail outlets, producers, manufacturers, distributors, and warehouses were deemed essential services by the Alberta Government on March 30, 2020. As a result, cannabis businesses and services continued to serve Albertans throughout the COVID-19 pandemic. 

Medical Cannabis Market Segmentation  

The global medical cannabis market is segmented into product type, application, end user, and region to provide a detailed assessment of the market. By product type, it is segmented into buds/marijuana flower and cannabis extracts. The cannabis extract segment includes oil, tinctures, and others include hash, dabs. Depending on application, the market is segregated into chronic pain, mental disorders, cancer, and others, including arthritis, epilepsy, migraine, and others. On the basis of end user, it is categorized into pharmaceutical, and research & development centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Medical Cannabis Market
By Product Type

Your browser does not support the canvas element.

Cannabis Extract segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Segment Review

Depending on product type, the cannabis extract segment dominated the global medical cannabis market in 2020, and is expected to remain dominant throughout the forecast period, owing to factors such as rise in preference for cannabis extracts such as oils and tinctures, legalization of marijuana for treatment of various chronic diseases, and new launches of cannabis extract products.

By application, the chronic pain segment led the global medical cannabis market in 2020, and is anticipated to continue this trend during the forecast period. This is attributed to increase in use of medical cannabis for effective treatment for chronic pain, owing to effectiveness in dulling the senses and anti-inflammatory properties of cannabis.

On the basis of end user, the pharmaceutical was the major shareholder in 2020, and is expected to remain dominant throughout the forecast period, owing to increase in use of cannabis in the pharmaceutical industry as well as rise in investments by pharma companies in CBD due to the health benefits of cannabis.

Medical Cannabis Market
By Application

Your browser does not support the canvas element.

Chronic Pain segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Snapshot of the Asia-Pacific medical cannabis market  

Asia-Pacific offers profitable opportunities for key players operating in the medical cannabis market, thereby registering the fastest growth rate during the forecast period, owing to increase in R&D activities for drug discovery using medical cannabis, rise in incidence of chronic disease such as cancer and osteoarthritis, and increase in awareness about benefits associated with medical cannabis.

In addition, factors such as increase in legalization and active research genetic development and modification of the plant as well as advancements in intellectual property rights of cannabis boost the growth of the market in the region. For instance, in January 2018, the Australian Government allowed cannabis producers in the region to export medical cannabis and its products to the global medical cannabis market.   

The key market players profiled in the report include Aurora marijuana Inc., Canopy Growth Corporation, Cronos Group Inc., Maricann Group, Inc., Medical Marijuana, Inc., OrganiGram Holding Inc., Terra Tech Corp., Tikun Olam Ltd., Tilray, Inc., and VIVO Cannabis Inc.

Medical Cannabis Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

North America is expected to experience growth at the highest rate, registering a CAGR of 21.20 % during the forecast period.

Get more information on this report : Request Sample Pages

Key Benefits for Stakeholders

  • The study provides an in-depth analysis of the global medical cannabis market along with the current trends and future estimations to explain the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the medical cannabis market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products of medical cannabis used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the medical cannabis market.

Key Market Segments

By Product Type

  • Buds/Marijuana Flower
  • Cannabis Extracts
  • Oil
  • Tinctures
  • Others 

By Application

  • Chronic Pain
  • Mental Disorders
  • Cancer
  • Others 

By End User

  • Pharmaceutical
  • Research & Development Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • Italy
    • Denmark
    • Poland
    • UK
    • Rest of Europe
  • Asia-Pacific
    • Thailand
    • Australia
    • New Zealand
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Rest of LAMEA

Key Market Players 

  • Aurora marijuana Inc.
  • Canopy Growth Corporation.
  • Cronos Group Inc.
  • Maricann Group, Inc.
  • Medical Marijuana, Inc.
  • OrganiGram Holding Inc.
  • Terra Tech Corp.
  • Tikun Olam Ltd.
  • Tilray, Inc.
  • VIVO Cannabis Inc.
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in legalization of cannabis across various regions
3.5.1.2.Rise in awareness among consumers regarding health benefits of cannabis and its growing medical application
3.5.1.3.Novel product development with increased R & D activities

3.5.2.Restraints

3.5.2.1.Complex regulatory structure for the usage of cannabis
3.5.2.2.Social stigma related to cannabis use

3.5.3.Opportunities

3.5.3.1.Emergence of cannabis legalization in Asia Pacific

3.5.4.Impact analysis

3.6.COVID-19 Impact analysis on the medical cannabis market

CHAPTER 4:MEDICAL CANNABIS MARKET, BY PRDUCT TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Buds / marijuana Flower

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Cannabis Extracts

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.3.4.Market size and forecast, by type
4.3.5.Oil

4.3.5.1.Market size and forecast

4.3.6.Tinctures

4.3.6.1.Market size and forecast

4.3.7.Others

4.3.7.1.Market size and forecast

CHAPTER 5:MEDICAL CANNABIS MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Chronic Pain

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Mental Disorders

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

5.4.Cancer

5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country

5.5.Others

5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country

CHAPTER 6:MEDICAL CANNABIS MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Pharmaceutical

6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country

6.3.Research and Development Centers

6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country

CHAPTER 7:MEDICAL CANNABIS MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country

7.2.2.1.U.S.

7.2.2.1.1.U.S. medical cannabis market, by product type
7.2.2.1.2.U.S. medical cannabis market, by application
7.2.2.1.3.U.S. medical cannabis market, by end user

7.2.2.2.Canada

7.2.2.2.1.Canada medical cannabis market, by product type
7.2.2.2.2.Canada medical cannabis market, by application
7.2.2.2.3.Canada medical cannabis market, by end user

7.2.2.3.Mexico

7.2.2.3.1.Mexico medical cannabis market, by product type
7.2.2.3.2.Mexico medical cannabis market, by application
7.2.2.3.3.Mexico medical cannabis market, by end user

7.2.3.North America market size and forecast, by product type
7.2.4.North America market size and forecast, by application
7.2.5.North America market size and forecast, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country

7.3.2.1.Germany

7.3.2.1.1.Germany medical cannabis market, by product type
7.3.2.1.2.Germany medical cannabis market, by application
7.3.2.1.3.Germany medical cannabis market, by end user

7.3.2.2.Italy

7.3.2.2.1.Italy medical cannabis market, by product type
7.3.2.2.2.Italy medical cannabis market, by application
7.3.2.2.3.Italy medical cannabis market, by end user

7.3.2.3.Denmark

7.3.2.3.1.Denmark medical cannabis market, by product type
7.3.2.3.2.Denmark medical cannabis market, by application
7.3.2.3.3.Denmark medical cannabis market, by end user

7.3.2.4.Poland

7.3.2.4.1.Poland medical cannabis market, by product type
7.3.2.4.2.Poland medical cannabis market, by application
7.3.2.4.3.Poland medical cannabis market, by end user

7.3.2.5.UK

7.3.2.5.1.UK medical cannabis market, by product type
7.3.2.5.2.UK medical cannabis market, by application
7.3.2.5.3.UK medical cannabis market, by end user

7.3.2.6.Rest of Europe

7.3.2.6.1.Rest of Europe medical cannabis market, by product type
7.3.2.6.2.Rest of Europe medical cannabis market, by application
7.3.2.6.3.Rest of Europe medical cannabis market, by end user

7.3.3.Europe market size and forecast, by product type
7.3.4.Europe market size and forecast, by application
7.3.5.Europe market size and forecast, by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country

7.4.2.1.Thailand

7.4.2.1.1.Thailand medical cannabis market, by product type
7.4.2.1.2.Thailand medical cannabis market, by application
7.4.2.1.3.Thailand medical cannabis market, by end user

7.4.2.2.Australia

7.4.2.2.1.Australia medical cannabis market, by product type
7.4.2.2.2.Australia medical cannabis market, by application
7.4.2.2.3.Australia medical cannabis market, by end user

7.4.2.3.New Zealand

7.4.2.3.1.New Zealand medical cannabis market, by product type
7.4.2.3.2.New Zealand medical cannabis market, by application
7.4.2.3.3.New Zealand medical cannabis market, by end user

7.4.2.4.Rest of Asia-Pacific

7.4.2.4.1.Rest of Asia-Pacific medical cannabis market, by product type
7.4.2.4.2.Rest of Asia-Pacific medical cannabis market, by application
7.4.2.4.3.Rest of Asia-Pacific medical cannabis market, by end user

7.4.3.Asia-Pacific market size and forecast, by product type
7.4.4.Asia-Pacific market size and forecast, by application
7.4.5.Asia-Pacific market size and forecast, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country

7.5.2.1.Brazil

7.5.2.1.1.Brazil medical cannabis market, by product type
7.5.2.1.2.Brazil medical cannabis market, by application
7.5.2.1.3.Brazil medical cannabis market, by end user

7.5.2.2.South Africa

7.5.2.2.1.South Africa medical cannabis market, by product type
7.5.2.2.2.South Africa medical cannabis market, by application
7.5.2.2.3.South Africa medical cannabis market, by end user

7.5.2.3.Rest of LAMEA

7.5.2.3.1.Rest of LAMEA medical cannabis market, by product type
7.5.2.3.2.Rest of LAMEA medical cannabis market, by application
7.5.2.3.3.Rest of LAMEA medical cannabis market, by end user

7.5.3.LAMEA market size and forecast, by product type
7.5.4.LAMEA market size and forecast, by application
7.5.5.LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

8.1.Aurora marijuana Inc.

8.1.1.Company overview
8.1.2.Operating business segments
8.1.3.Product portfolio
8.1.4.Business performance
8.1.5.Key strategic moves and developments

8.2.Canopy Growth Corporation

8.2.1.Company overview
8.2.2.Operating business segments
8.2.3.Product portfolio
8.2.4.Business performance
8.2.5.Key strategic moves and developments

8.3.Cronos Group Inc.

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments

8.4.Maricann Group, Inc.

8.4.1.Company overview
8.4.2.Operating business segments
8.4.3.Product portfolio

8.5.Medical Marijuana, Inc.

8.5.1.Company overview
8.5.2.Operating business segments
8.5.3.Product portfolio
8.5.4.Business performance
8.5.5.Key strategic moves and developments

8.6.OrganiGram Holding Inc.

8.6.1.Company overview
8.6.2.Operating business segments
8.6.3.Product portfolio
8.6.4.Business performance
8.6.5.Key strategic moves and developments

8.7.Terra Tech Corporation

8.7.1.Company overview
8.7.2.Operating business segments
8.7.3.Product portfolio
8.7.4.Business performance
8.7.5.Key strategic moves and developments

8.8.Tikun Olam Ltd.

8.8.1.Company overview
8.8.2.Operating business segments
8.8.3.Product portfolio

8.9.Tilray, Inc.

8.9.1.Company overview
8.9.2.Operating business segments
8.9.3.Product portfolio
8.9.4.Business performance
8.9.5.Key strategic moves and developments

8.10.VIVO Cannabis Inc.

8.10.1.Company overview
8.10.2.Operating business segments
8.10.3.Product portfolio
8.10.4.Business performance
8.10.5.Key strategic moves and developments

LIST OF TABLES

TABLE 01.GLOBAL MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 02.MEDICAL CANNABIS MARKET FOR BUDS/MARIJUANA FLOWER, BY REGION, 2020-2030($MILLION)
TABLE 03.MEDICAL CANNABIS MARKET FOR CANNABIS EXTRACTS, BY REGION, 2020-2030($MILLION)
TABLE 04.MEDICAL CANNABIS MARKET, FOR CANNABIS EXTRACTS, BY TYPE, 2020–2030, ($MILLION)
TABLE 05.GLOBAL MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 06.MEDICAL CANNABIS MARKET FOR CHRONIC PAIN, BY REGION, 2020-2030($MILLION)
TABLE 07.MEDICAL CANNABIS MARKET FOR MENTAL DISORDERS, BY REGION, 2020-2030($MILLION)
TABLE 08.MEDICAL CANNABIS MARKET FOR CANCER, BY REGION, 2020-2030($MILLION)
TABLE 09.MEDICAL CANNABIS MARKET FOR OTHERS, BY REGION, 2020-2030($MILLION)
TABLE 10.GLOBAL MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 11.MEDICAL CANNABIS MARKET FOR PHARMACEUTICAL, BY REGION, 2020-2030($MILLION)
TABLE 12.MEDICAL CANNABIS MARKET FOR RESEARCH AND DEVELOPMENT CENTERS, BY REGION, 2020-2030($MILLION)
TABLE 13.MEDICAL CANNABIS MARKET, BY REGION, 2020-2030($MILLION)
TABLE 14.NORTH AMERICA MEDICAL CANNABIS MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 15.U.S. MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 16.U.S. MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 17.U.S. MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 18.CANADA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 19.CANADA MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 20.CANADA MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 21.MEXICO MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 22.MEXICO MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 23.MEXICO MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 24.NORTH AMERICA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 25.NORTH AMERICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 26.NORTH AMERICA MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 27.EUROPE MEDICAL CANNABIS MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 28.GERMANY MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 29.GERMANY MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 30.GERMANY MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 31.ITALY MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 32.ITALY MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 33.ITALY MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 34.DENMARK MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 35.DENMARK MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 36.DENMARK MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 37.PLOAND MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 38.POLAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 39.POLAND MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 40.UK MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 41.UK MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 42.UK MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 43.REST OF EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 44.REST OF EUROPE MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 45.REST OF EUROPE MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 46.EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 47.EUROPE MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 48.EUROPE MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 49.ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 50.THAILAND MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 51.THAILAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 52.THAILAND MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 53.AUSTRALIA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 54.AUSTRALIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 55.AUSTRALIA MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 56.NEW ZEALAND MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 57.NEW ZEALAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 58.NEW ZEALAND MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 59.REST OF ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 60.REST OF ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 61.REST OF ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 62.ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 63.ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 64.ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 65.LAMEA MEDICAL CANNABIS MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 66.BRAZIL MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 67.BRAZIL MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 68.BRAZIL MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 69.SOUTH AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 70.SOUTH AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 71.SOUTH AFRICA MEDICAL CANNABIS MARKET, BY END USER 2020-2030($MILLION)
TABLE 72.REST OF LAMEA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 73.REST OF LAMEA MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 74.REST OF LAMEA MEDICAL CANNABIS MARKET, END USER, 2020-2030($MILLION)
TABLE 75.LAMEA MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2020-2030($MILLION)
TABLE 76.LAMEA MEDICAL CANNABIS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 77.LAMEA MEDICAL CANNABIS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 78.AURORA CANNABIS: COMPANY SNAPSHOT
TABLE 79.AURORA CANNABIS: OPERATING SEGMENTS
TABLE 80.AURORA CANNABIS: PRODUCT PORTFOLIO
TABLE 81.AURORA CANNABIS: KEY DEVELOPMENTS
TABLE 82.CANOPY GROWTH CORPORATION: COMPANY SNAPSHOT
TABLE 83.CANOPY GROWTH CORPORATION: OPERATING SEGMENTS
TABLE 84.CANOPY GROWTH CORPORATION: PRODUCT PORTFOLIO
TABLE 85.AURORA CANNABIS: KEY DEVELOPMENTS
TABLE 86.CRONOS GROUP INC.: SNAPSHOT
TABLE 87.CRONOS GROUP INC.: OPERATING SEGMENTS
TABLE 88.CRONOS GROUP INC.: PRODUCT PORTFOLIO
TABLE 89.CRONOS GROUP: KEY DEVELOPMENTS
TABLE 90.MARICANN GROUP, INC.: COMPANY SNAPSHOT
TABLE 91.MARICANN GROUP, INC.: OPERATING SEGMENTS
TABLE 92.MARICANN GROUP, INC.: PRODUCT PORTFOLIO
TABLE 93.MEDICAL MARIJUANA, INC.: COMPANY SNAPSHOT
TABLE 94.MEDICAL MARIJUANA, INC.: OPERATING SEGMENTS
TABLE 95.MEDICAL MARIJUANA, INC.: PRODUCT PORTFOLIO
TABLE 96.MEDICAL MARIJUANA: KEY DEVELOPMENTS
TABLE 97.ORGANIGRAM HOLDING INC.: COMPANY SNAPSHOT
TABLE 98.ORGANIGRAM HOLDING INC.: OPERATING SEGMENTS:
TABLE 99.ORGANIGRAM HOLDING INC.: PRODUCT PORTFOLIO
TABLE 100.ORGANIGRAM HOLDING: KEY DEVELOPMENTS
TABLE 101.TERRA TECH CORP.: COMPANY SNAPSHOT
TABLE 102.TERRA TECH CORP.: OPERATING SEGMENTS
TABLE 103.TERRA TECH CORP.: PRODUCT PORTFOLIO
TABLE 104.TERRA TECH CORP: KEY DEVELOPMENTS
TABLE 105.TIKUN OLAM LTD.: COMPANY SNAPSHOT
TABLE 106.TIKUN OLAM LTD.: OPERATING SEGMENTS
TABLE 107.TIKUN OLAM LTD.: PRODUCT PORTFOLIO
TABLE 108.TILRAY, INC.: COMPANY SNAPSHOT
TABLE 109.TILRAY, INC.: OPERATING SEGMENTS
TABLE 110.TILRAY, INC.: PRODUCT PORTFOLIO
TABLE 111.TILRAY, INC.: KEY DEVELOPMENTS
TABLE 112.VIVO CANNABIS INC.: COMPANY SNAPSHOT
TABLE 113.VIVO CANNABIS INC.: OPERATING SEGMENTS
TABLE 114.VIVO CANNABIS INC.: PRODUCT PORTFOLIO
TABLE 115.VIVO CANNABIS INC.: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 01.MEDICAL CANNABIS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2019-2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.HIGH INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF MEDICAL CANNABIS MARKET FOR BUDS/MARIJUANA FLOWER, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF MEDICAL CANNABIS MARKET FOR CANNABIS EXTRACTS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15.MEDICAL CANNABIS MARKET FOR OIL, 2020–2030, ($MILLION)
FIGURE 16.MEDICAL CANNABIS MARKET FOR TINCTURES, 2020–2030, ($MILLION)
FIGURE 17.MEDICAL CANNABIS MARKET FOR OTHERS, 2020–2030, ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS MEDICAL CANNABIS MARKET FOR CHRONIC PAIN, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF MEDICAL CANNABIS MARKET FOR MENTAL DISORDERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF MEDICAL CANNABIS MARKET FOR CANCER, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF MEDICAL CANNABIS MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF MEDICAL CANNABIS MARKET FOR PHARMACEUTICAL, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS OF MEDICAL CANNABIS MARKET FOR RESEARCH AND DEVELOPMENT CENTERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 24.AURORA CANNABIS: NET SALES, 2019–2021 ($MILLION)
FIGURE 25.AURORA CANNABIS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 26.AURORA CANNABIS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 27.CANOPY GROWTH CORPORATION: NET SALES, 2019–2021 ($MILLION)
FIGURE 28.CANOPY GROWTH CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 29.CANOPY GROWTH CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 30.CRONOS GROUP INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 31.CRONOS GROUP INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 32.CRONOS GROUP INC.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 33.MEDICAL MARIJUANA, INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 34.ORGANIGRAM HOLDING INC.: NET SALES, 2019–2021 ($MILLION)
FIGURE 35.TERRA TECH CORP.: NET SALES, 2018–2020 ($MILLION)
FIGURE 36.TILRAY, INC.: NET SALES, 2019–2021 ($MILLION)
FIGURE 37.TILRAY, INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 38.TILRAY, INC.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 39.VIVO CANNABIS INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 40.VIVO CANNABIS INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 41.VIVO CANNABIS INC.: REVENUE SHARE BY REGION, 2020 (%)

 
 

Cannabis is a psychoactive drug that is derived from the cannabis plant of the Cannabaceae family. For several years, it has been used medicinally and has wide range of applications in treatment of various diseases, including chronic pain, cancer, depression, diabetes, arthritis, glaucoma, epilepsy, migraines, AIDS, and Alzheimer’s.

Legalization of cannabis across various regions, rise in awareness among consumers regarding health benefits of cannabis and its growing medical application, and novel product development with increased R & D activities are some factors, which boost growth of the market. Furthermore, cannabis legalization in Asia-Pacific is expected to create a lucrative opportunity for market growth. However, complex regulatory structure for the usage of cannabis, and social stigma related to cannabis are expected to hinder growth of the market. 

North America are expected to offer lucrative opportunities to the market during the forecast period, owing to legalization of cannabis in both the U.S. and Canada for medical and recreational purposes and increase in research and development (R&D) activities in the medical applications of cannabis.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of Medical Cannabis market is $6822.21 million in 2020.

A. The forcast period for Medical Cannabis market is 2021 to 2030

A. The market value of Medical Cannabis market in 2021 is $7990.18 million.

A. The base year is 2020 in Medical Cannabis market

A. Top companies such as Medical Marijuana, VIVO Cannabis Inc., Canopy Growth Corporation, Aurora Marijuana, Tilray Inc., and Cronos Group held a high market position in 2020.

A. Cannabis Extract segment is the most influencing segment owing to growing preference for cannabis extracts such as oils and tinctures, rising legalization of marijuana for treatment of various chronic diseases, and new launches of cannabis extract products.

A. Rise in legalization of cannabis across various regions, growth in awareness among consumers regarding health benefits of cannabis and its growing medical application and novel product development with increased R & D activities are some factors which boost growth of the market.

A. Asia-Pacific is expected to experience the highest growth rate during the forecast period, owing to increase in R&D activities for drug discovery using medical cannabis, rise in incidences of chronic disease such as cancer, Osteoarthritis and others, ana increase in awareness about benefits associated with medical cannabis.

A. Medical cannabis also known as medical marijuana (MMJ), is cannabis and cannabinoids that are prescribed by physicians for their patients for the treatment of various diseases including chronic pain, cancer, depression, diabetes, arthritis, glaucoma, epilepsy, migraines, AIDS and Alzheimer’s among others.

A. Medical cannabis used for the treatment of various diseases including chronic pain, cancer, depression, diabetes, arthritis, glaucoma, epilepsy, migraines, AIDS and Alzheimer’s among others.

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Medical Cannabis Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers